Interferon alpha and 13 cis retinoid acid in the therapy of metastatic renal cell carcinoma.

被引：0
|
作者：
Ostrizkova, L [1 ]
Kocak, I [1 ]
Palacova, M [1 ]
Kebedeova, D [1 ]
机构：
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
359
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [21] Subcutaneous administration of interferon alpha and gamma in patients with metastatic renal cell carcinoma
    Koga, S
    Nishikido, M
    Matsuya, F
    Kanetake, H
    Saito, Y
    ANTICANCER RESEARCH, 1999, 19 (6C) : 5547 - 5550
  • [22] INTERLEUKIN-2 AND INTERFERON-ALPHA-2A OUTPATIENT THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    LIPTON, A
    HARVEY, H
    GIVANT, E
    HOPPER, K
    LAWLER, J
    MATTHEWS, Y
    HIRSH, M
    ZEFFREN, J
    JOURNAL OF IMMUNOTHERAPY, 1993, 13 (02) : 122 - 129
  • [23] The role of cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Alnimer, Yanal Mufeed
    Qasrawi, Ayman
    Katato, Khalil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Linear muscle segmentation for metastatic renal cell carcinoma.
    Nicaise, Edouard
    Schmeusser, Benjamin
    Ali, Adil
    Midenberg, Eric
    Palacios, Arnold Raul
    Kearns, Ethan
    Ambadi, Sriram
    Patil, Dattatraya H.
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Psutka, Sarah P.
    Nazha, Bassel
    Brown, Jacqueline T.
    Ogan, Kenneth
    Bilen, Mehmet Asim
    Master, Viraj A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 380 - 380
  • [25] Treatment compliance in patients with metastatic renal cell carcinoma.
    Chen, C.
    Hess, G. P.
    Hill, J. W.
    Liu, Z.
    Agarwala, S. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] New treatment approaches for metastatic renal cell carcinoma.
    Nanus D.M.
    Current Oncology Reports, 2000, 2 (5) : 417 - 422
  • [27] Extracranial palliative radiotherapy for metastatic renal cell carcinoma.
    Kwon, Young Suk
    Hsu, Eric
    Stein, Maggie
    Christie, Alana
    Garant, Aurelie
    Wang, Andrew Zhuang
    Yang, Daniel X.
    Yen, Allen
    Miljanic, Mihailo
    Courtney, Kevin Dale
    Hammers, Hans J.
    Zhang, Tian
    Arafat, Waddah
    Qin, Qian
    Cole, Suzanne
    Brugarolas, James
    Timmerman, Robert D.
    Hannan, Raquibul
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Multicenter phase II trial of interleukin-2, interferon-α, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma
    Stadler, WM
    Kuzel, T
    Dumas, M
    Vogelzang, NJ
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1820 - 1825
  • [29] METASTATIC ADENOCARCINOMA OF THE ENDOMETRIUM TREATED WITH 13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA
    KUDELKA, AP
    FREEDMAN, RS
    EDWARDS, CL
    LIPPMAN, SM
    TORNOS, CS
    KRAKOFF, IH
    KAVANAGH, JJ
    ANTI-CANCER DRUGS, 1993, 4 (03) : 335 - 337
  • [30] Dendritic cell therapy in combination with interferon-α for the treatment of metastatic renal cell carcinoma
    Tatsugami, Katsunori
    Eto, Masatoshi
    Harano, Masahiko
    Hamaguchi, Masumitsu
    Miyamoto, Toshihiro
    Morisaki, Takashi
    Furue, Masutaka
    Akashi, Koichi
    Naito, Seiji
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (08) : 694 - 698
12345